| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $859.8M | $844.0M | $777.7M |
| YoY Revenue Growth % | +1.9% | +8.5% | — |
| Gross Profit | $604.8M | $593.0M | — |
| Gross Margin % | 70.3% | 70.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $11.6M | $35.0M | -$84.3M |
| Operating Margin % | 1.3% | 4.2% | -10.8% |
| Net Income (GAAP) | $23.4M | $25.5M | -$152.8M |
| EBITDA (Normalized) | $17.6M | $37.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $153.8M | $171.7M | $104.3M |
| Capital Expenditures (CapEx) | $7.6M | $3.4M | — |
| Free Cash Flow (FCF) | $146.2M | $168.2M | $104.3M |
| FCF Margin % | 17.0% | 19.9% | 13.4% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $246.7M | $334.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $154.7M | $17.7M | — |